Human fetuin/α2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer

European Journal of Gastroenterology and Hepatology

Volumn 14, Issue 4, 2002, Pages 389-394

  Kalabay, László ^a   Jakab, Lajos ^a   Prohászka, Zoltán ^a   Füst, George ^a   Benkö, Zsuzsa ^a   Telegdy, László ^a   Lörincz, Zsolt ^a   Závodszky, Péter ^a   Arnaud, Philippe ^a   Fekete, Béla ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Acute phase reaction; Acute viral hepatitis; Fetuin 2HS glycoprotein; Liver cancer; Liver cirrhosis; Transferrin

Indexed keywords

ALBUMIN; FETUIN; GLYCOPROTEIN; PROTHROMBIN; TRANSFERRIN; ALPHA FETOPROTEIN; ALPHA2HS GLYCOPROTEIN; CYSTATIN; PLASMA PROTEIN;

ACUTE PHASE RESPONSE; ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HEPATITIS NON A NON B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNODIFFUSION; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SURVIVAL; TRANSFERRIN BLOOD LEVEL; VIRUS HEPATITIS; ADOLESCENT; AGED; BLOOD; LIVER FUNCTION TEST; LIVER TUMOR; MIDDLE AGED; STATISTICAL MODEL;

ACUTE-PHASE REACTION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BLOOD PROTEINS; CYSTATINS; FEMALE; HUMANS; IMMUNODIFFUSION; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; TRANSFERRIN;

EID: 0036010899     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200204000-00009     Document Type: Article

References (26)

1. 2 HS glycoprotein during the inflammatory process
2. 2HS glycoprotein in mineralizing human bone
3. The serum protein alpha2-HS glycoprotein-fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells
4. 2HS) in human embryonic and fetal development
5. 2HS-glycoprotein and its accumulation in bone
6. Effect of phosphorylated rat fetuin on the growth of hepatocytes in primary cultures in the presence of human hepatocyte-growth factor. Evidence that phosphorylated fetuin is a natural modulator of hepatocyte-growth factor
7. Fetuin/alpha2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist
8. 2-HS glycoprotein is produced in insect cells as a full-length inhibitor of the insulin receptor tyrosine kinase
9. 2-HS-glycoprotein on the mitogen induced lymphocyte blastic transformation and IL-2 production
10. Enzymes and circulating proteins as markers of alcohol abuse
11. Modifications of concanavalin A patterns of α1-acid glycoprotein and α2-HS glycoprotein in alcoholic liver disease
12. Decreased serum alfa2-HS-glycoprotein concentration in patients with primary biliary cirrhosis
13. Isolation of human α2-HS glycoprotein synthesized by Sf9 cells
14. Quantitative determination of single serum proteins during acute hepatitis in childhood
15. 2-HS glycoprotein gene in rats
16. The synthesis of human α-2-HS glycoprotein is down-regulated by cytokines in hepatoma HepG2 cells
17. Serum levels of interleukin-1α, interleukin-1β, interleukin-6, and tumor necrosis factor in patients with acute viral hepatitis
18. Study on proinflammatory cytokines (IL-Iβ, IL-6, TNFα) and IL-2 in patients with acute hepatitis B
19. Serum levels of cytokines in hepatitis C-related liver disease: A longitudinal study
20. Interleukin-6 production by peripheral monocytes in patients with chronic liver disease and acute viral hepatitis
21. Elevated serum interleukin-6 levels in patients with acute hepatitis
22. Circulating proinflammatory cytokines (IL-1β, TNFα and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis
23. Increased serum interleukin-6 level and reduction of hepatic acute phase response after major hepatectomy
24. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
25. 2-HS-glycoprotein concentration in patients with hematological malignancies: A follow up study
26. Interleukin-6 plasma level in patients with primary biliary cirrhosis and other liver diseases